Skip to main content
Erschienen in: Surgical Endoscopy 8/2020

13.01.2020 | 2019 EAES Oral

Does endoscopic sleeve gastroplasty stand the test of time? Objective assessment of endoscopic ESG appearance and its relation to weight loss in a large group of consecutive patients

verfasst von: Margherita Pizzicannella, Alfonso Lapergola, Claudio Fiorillo, Andrea Spota, Pietro Mascagni, Michel Vix, Didier Mutter, Guido Costamagna, Jacques Marescaux, Lee Swanström, Silvana Perretta

Erschienen in: Surgical Endoscopy | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Endoscopic sleeve gastroplasty (ESG) is a promising bariatric treatment. Gastric volume reduction and delayed gastric emptying are the probable mechanisms driving weight loss. However, there are concerns regarding the overtime ESG effectiveness. This study aims to evaluate the correlation between endoscopic gastroplasty integrity overtime and weight loss.

Patients and methods

Patients undergoing follow-up endoscopy (6 and 12 months) after ESG were included. ESG were classified in three groups according to endoscopic appearance: open when all the stiches were loose; partially intact if at least one stitch was loose; intact if all the stitches were present and tight. Initial BMI, excess weight loss (%EWL) and total weight loss (%TWL) at 6 and 12 months were assessed against gastroplasty endoscopic appearance.

Results

From October 2016 to April 2019, 133 patients underwent ESG, 87 (65.4%) had a follow-up EGD at 6 months. ESG was open in six cases (6.9%), partially intact in 38 (43.7%) and intact in 43 (49.4%). The overall %EWL and %TWL was 34.5 ± 19.8 and 13.2 ± 7.4, respectively; 25.7 ± 26.9 and 11.8 ± 11.8 for the open group, 30.8 ± 20.1 and 12.4 ± 7.8 for the partially intact group; 39.1 ± 19.7 and 14.0 ± 6.4 for the intact gastroplasty. Forty-one patients underwent a 12 months endoscopy: 10 (24.4%) had an intact ESG, 24 (58.5%) had a partially intact gastroplasty, and in 7 (17.0%) cases the sutures were lost. Overall %EWL and %TWL at 12 months was 34.3 ± 21.9 and 13.1 ± 8.1: 19.3 ± 13.4 and 8.9 ± 6.1 for the open group; 36.0 ± 24.2 and 13.1 ± 8.9 for the partially intact group; 40.3 ± 17.3 and 17.2 ± 5.4 for the intact group. ESG appearance correlated with preoperative BMI (r 0.34; p 0.001) and %EWL at 6 months (r 0.22; p 0.035) and 12 months (r 0.29; p 0.065).

Conclusion

This preliminary work shows that weight loss correlates with ESG endoscopic appearance over time. Initial BMI predicts endoscopic suture duration over time. Larger studies and longer follow-up are needed.
Literatur
1.
Zurück zum Zitat Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet (London, England) 377:557–567CrossRef Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet (London, England) 377:557–567CrossRef
2.
Zurück zum Zitat Collins J, Meng C, Eng A (2016) Psychological impact of severe obesity. Curr Obes Rep 5:435–440CrossRef Collins J, Meng C, Eng A (2016) Psychological impact of severe obesity. Curr Obes Rep 5:435–440CrossRef
3.
Zurück zum Zitat Kolotkin RL, Meter K, Williams GR (2001) Quality of life and obesity. Obes Rev 2:219–229CrossRef Kolotkin RL, Meter K, Williams GR (2001) Quality of life and obesity. Obes Rev 2:219–229CrossRef
4.
Zurück zum Zitat Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (London, England) 373:1083–1096CrossRef Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (London, England) 373:1083–1096CrossRef
5.
Zurück zum Zitat Haslam DW, James WP (2005) Obesity. Lancet (London, England) 366:1197–1209CrossRef Haslam DW, James WP (2005) Obesity. Lancet (London, England) 366:1197–1209CrossRef
6.
Zurück zum Zitat Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693CrossRef Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693CrossRef
7.
Zurück zum Zitat Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, Ahlin S, Anveden A, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lonroth H, Narbro K, Naslund I, Olbers T, Svensson PA, Carlsson LM (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65CrossRef Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, Ahlin S, Anveden A, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lonroth H, Narbro K, Naslund I, Olbers T, Svensson PA, Carlsson LM (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65CrossRef
8.
Zurück zum Zitat Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, Jacobson P, Lonroth H, Maglio C, Naslund I, Pirazzi C, Romeo S, Sjoholm K, Sjostrom E, Wedel H, Svensson PA, Sjostrom L (2012) Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 367:695–704CrossRef Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, Jacobson P, Lonroth H, Maglio C, Naslund I, Pirazzi C, Romeo S, Sjoholm K, Sjostrom E, Wedel H, Svensson PA, Sjostrom L (2012) Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 367:695–704CrossRef
9.
Zurück zum Zitat Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A, Bouchard C, Carlsson B, Karason K, Lonroth H, Naslund I, Sjostrom E, Taube M, Wedel H, Svensson PA, Sjoholm K, Carlsson LM (2014) Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311:2297–2304CrossRef Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A, Bouchard C, Carlsson B, Karason K, Lonroth H, Naslund I, Sjostrom E, Taube M, Wedel H, Svensson PA, Sjoholm K, Carlsson LM (2014) Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311:2297–2304CrossRef
10.
Zurück zum Zitat Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, Mcmahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S (2013) Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring, Md) 21(Suppl 1):S1–S27CrossRef Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, Mcmahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S (2013) Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring, Md) 21(Suppl 1):S1–S27CrossRef
11.
Zurück zum Zitat Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS, Rajan E, Topazian MD, Gostout CJ (2017) Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol 15:37–43.E31CrossRef Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS, Rajan E, Topazian MD, Gostout CJ (2017) Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol 15:37–43.E31CrossRef
12.
Zurück zum Zitat Abu Dayyeh BK, Rajan E, Gostout CJ (2013) Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc 78:530–535CrossRef Abu Dayyeh BK, Rajan E, Gostout CJ (2013) Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc 78:530–535CrossRef
13.
Zurück zum Zitat Sharaiha RZ, Kedia P, Kumta N, Defilippis EM, Gaidhane M, Shukla A, Aronne LJ, Kahaleh M (2015) Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy 47:164–166PubMed Sharaiha RZ, Kedia P, Kumta N, Defilippis EM, Gaidhane M, Shukla A, Aronne LJ, Kahaleh M (2015) Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy 47:164–166PubMed
14.
Zurück zum Zitat Lopez-Nava G, Sharaiha RZ, Vargas EJ, Bazerbachi F, Manoel GN, Bautista-Castano I, Acosta A, Topazian MD, Mundi MS, Kumta N, Kahaleh M, Herr AM, Shukla A, Aronne L, Gostout CJ, Abu Dayyeh BK (2017) Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 27:2649–2655CrossRef Lopez-Nava G, Sharaiha RZ, Vargas EJ, Bazerbachi F, Manoel GN, Bautista-Castano I, Acosta A, Topazian MD, Mundi MS, Kumta N, Kahaleh M, Herr AM, Shukla A, Aronne L, Gostout CJ, Abu Dayyeh BK (2017) Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 27:2649–2655CrossRef
15.
Zurück zum Zitat Sartoretto A, Sui Z, Hill C, Dunlap M, Rivera AR, Khashab MA, Kalloo AN, Fayad L, Cheskin LJ, Marinos G, Wilson E, Kumbhari V (2018) Endoscopic sleeve gastroplasty (Esg) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, International Multicenter Study. Obes Surg 28:1812–1821CrossRef Sartoretto A, Sui Z, Hill C, Dunlap M, Rivera AR, Khashab MA, Kalloo AN, Fayad L, Cheskin LJ, Marinos G, Wilson E, Kumbhari V (2018) Endoscopic sleeve gastroplasty (Esg) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, International Multicenter Study. Obes Surg 28:1812–1821CrossRef
16.
Zurück zum Zitat Khan Z, Khan MA, Hajifathalian K, Shah S, Abdul M, Saumoy M, Aronne L, Lee W, Rz S (2019) Efficacy of endoscopic interventions for the management of obesity: a meta-analysis to compare endoscopic sleeve gastroplasty, aspireassist, and primary obesity surgery endolumenal. Obes Surg 29(7):2287–2298CrossRef Khan Z, Khan MA, Hajifathalian K, Shah S, Abdul M, Saumoy M, Aronne L, Lee W, Rz S (2019) Efficacy of endoscopic interventions for the management of obesity: a meta-analysis to compare endoscopic sleeve gastroplasty, aspireassist, and primary obesity surgery endolumenal. Obes Surg 29(7):2287–2298CrossRef
17.
Zurück zum Zitat Lopez-Nava G, Galvao MP, Da Bautista-Castano I, Jimenez A, De Grado T, Fernandez-Corbelle JP (2015) Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy 47:449–452CrossRef Lopez-Nava G, Galvao MP, Da Bautista-Castano I, Jimenez A, De Grado T, Fernandez-Corbelle JP (2015) Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy 47:449–452CrossRef
18.
Zurück zum Zitat Sharaiha RZ, Kumta NA, Saumoy M, Desai AP, Sarkisian AM, Benevenuto A, Tyberg A, Kumar R, Igel L, Verna EC, Schwartz R, Frissora C, Shukla A, Aronne LJ, Kahaleh M (2017) Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol 15:504–510CrossRef Sharaiha RZ, Kumta NA, Saumoy M, Desai AP, Sarkisian AM, Benevenuto A, Tyberg A, Kumar R, Igel L, Verna EC, Schwartz R, Frissora C, Shukla A, Aronne LJ, Kahaleh M (2017) Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol 15:504–510CrossRef
19.
Zurück zum Zitat Alqahtani A, Al-Darwish A, Ae M, Ya A, Elahmedi M (2018) Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc 89:1132–1138CrossRef Alqahtani A, Al-Darwish A, Ae M, Ya A, Elahmedi M (2018) Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc 89:1132–1138CrossRef
20.
Zurück zum Zitat Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, Thompson CC, Banerjee S (2015) Asge bariatric endoscopy task force systematic review and meta-analysis assessing the Asge Pivi thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 82(425–438):E425CrossRef Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, Thompson CC, Banerjee S (2015) Asge bariatric endoscopy task force systematic review and meta-analysis assessing the Asge Pivi thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 82(425–438):E425CrossRef
21.
Zurück zum Zitat Manning S, Pucci A, Carter NC, Elkalaawy M, Querci G, Magno S, Tamberi A, Finer N, Fiennes AG, Hashemi M, Jenkinson AD, Anselmino M, Santini F, Adamo M, Batterham RL (2014) Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc 6:1484–1491 Manning S, Pucci A, Carter NC, Elkalaawy M, Querci G, Magno S, Tamberi A, Finer N, Fiennes AG, Hashemi M, Jenkinson AD, Anselmino M, Santini F, Adamo M, Batterham RL (2014) Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc 6:1484–1491
22.
Zurück zum Zitat Galvao-Neto MD, Grecco E, Souza TF, Quadros LG, Silva LB, Campos JM (2016) Endoscopic sleeve gastroplasty—minimally invasive therapy for primary obesity treatment. Arquivos Brasileiros De Cirurgia Digestiva 29(suppl 1):95–97CrossRef Galvao-Neto MD, Grecco E, Souza TF, Quadros LG, Silva LB, Campos JM (2016) Endoscopic sleeve gastroplasty—minimally invasive therapy for primary obesity treatment. Arquivos Brasileiros De Cirurgia Digestiva 29(suppl 1):95–97CrossRef
23.
Zurück zum Zitat Jain D, Bhandari BS, Arora A, Singhal S (2017) Endoscopic sleeve gastroplasty—a new tool to manage obesity. Clin Endosc 50:552–561CrossRef Jain D, Bhandari BS, Arora A, Singhal S (2017) Endoscopic sleeve gastroplasty—a new tool to manage obesity. Clin Endosc 50:552–561CrossRef
24.
Zurück zum Zitat Brethauer SA, Chand B, Schauer PR, Thompson CC (2012) Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of trim trial. Surg Obes Relat Dis 8:296–303CrossRef Brethauer SA, Chand B, Schauer PR, Thompson CC (2012) Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of trim trial. Surg Obes Relat Dis 8:296–303CrossRef
25.
Zurück zum Zitat Contreras JE, Santander C, Court I, Bravo J (2013) Correlation between age and weight loss after bariatric surgery. Obes Surg 23:1286–1289CrossRef Contreras JE, Santander C, Court I, Bravo J (2013) Correlation between age and weight loss after bariatric surgery. Obes Surg 23:1286–1289CrossRef
26.
Zurück zum Zitat Susmallian S, Raziel A, Barnea R, Paran H (2019) Bariatric surgery in older adults: should there be an age limit? Medicine 98:E13824CrossRef Susmallian S, Raziel A, Barnea R, Paran H (2019) Bariatric surgery in older adults: should there be an age limit? Medicine 98:E13824CrossRef
Metadaten
Titel
Does endoscopic sleeve gastroplasty stand the test of time? Objective assessment of endoscopic ESG appearance and its relation to weight loss in a large group of consecutive patients
verfasst von
Margherita Pizzicannella
Alfonso Lapergola
Claudio Fiorillo
Andrea Spota
Pietro Mascagni
Michel Vix
Didier Mutter
Guido Costamagna
Jacques Marescaux
Lee Swanström
Silvana Perretta
Publikationsdatum
13.01.2020
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 8/2020
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07329-1

Weitere Artikel der Ausgabe 8/2020

Surgical Endoscopy 8/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.